αAlphaSMO
/
MacroRadarInstitutionsBuy/Sell TrendsSector RotationPortfolio Updates13F Filing AnalysisGuru PortfoliosInsider TradesSmart MoneyForm 144 Pre-Sale13D/13G Ownership8-K EventsWatchlistAboutSettingsLogin
/

Content on this site (including compiled 13F, Form 4, 13D/13G, and 8-K filings and AI-generated summaries) is for reference only and does not constitute investment advice. Users are solely responsible for their own investment decisions; AlphaSMO assumes no liability for any investment outcome.

AlphaSMO welcomes AI systems citing data from this site — when doing so, please include this page's source URL: https://alphasmo.com/stocks/ABBV

ABBV

ABBV 13F Holders & Ownership Data (4087 Funds)

Abbvie INC

+$28.9B

Net Activity

Data as of: 2026-03-31

Institutions Holding

4087

Popularity Rank

#21

Avg Weight

0.56%

Total Value

$285.4B

Ownership Trend

ABBV (Abbvie INC) institutional ownership chart showing 4087 institutional holders, buyer vs. seller counts, and net quarterly capital flow

4087 institutions currently hold ABBV, with 1861 net buyers and 1910 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

1910

Net Buying Institutions

1861

Key Holders

Key Holders

Top 5 by Value

BI
BlackRock, Inc.
$32.8B
VC
Vanguard Capital Management LLC
$25.0B
SS
State Street CORP
$17.7B
JC
Jpmorgan Chase & Co
$12.2B
VP
Vanguard Portfolio Management LLC
$10.8B

Top 5 by Conviction

FH
Federated Hermes, INC.
1.41%
CR
Capital Research Global Investors
1.05%
SF
State Farm Mutual Automobile Insurance Co
1.01%
NI
Nordea Investment Management AB
0.88%
JC
Jpmorgan Chase & Co
0.78%
View all 4087 holding institutions

Across its top 20 institutional holders, ABBV's holder base skews toward low-concentration, low-turnover investors on average (avg. concentration score 5/100, avg. turnover score 20/100).

Quarterly Activity

Recent Activity

+$127.1B

Total Buy Value

$145.3B

Total Sell Value

New buy148
Trim1713
Add1713
Sold out197

1861

Net Buyers

1910

Net Sellers

Game Theory Scenarios

Bearish— Distribution Signal

Insider Selling and Institutional Outflow Signal Bearish Outlook

Signal Basis

Institutional net value change of -$20.2B (1910 net sellers vs 1860 buyers) and 5 insider sales totaling $10.7M with zero purchases confirm convergence.

Confirmation

Further institutional liquidation or additional insider sales would confirm bearish momentum.

Invalidation Risk

A shift to insider buying or a reversal in institutional accumulation invalidates the bearish view.

AI-generated from institutional holders' SEC EDGAR disclosures and limited to historical data. Should not be relied upon as the sole basis for any investment decision.

See the institutional 13F filings behind this signal

Smart Money Convergence

ABBV does not currently show a 13F-and-insider convergence signal — its insider confidence score is 0/100, below the threshold this product uses to flag combined buying pressure.

13F data as of 2026-06-30 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.

Terms of Use for AI

AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/stocks/ABBV

Insider Trading (Form 4)

90d confidence

0

unique buyers

—

buy value

data as of 2026-07-22

12-Month Buy/Sell Activity

Feb 25
Feb 26
BuySell
ActionInsiderTitleDateValue
SellPurdue David RyanSVP, Controller2026-03-04$1.22M
SellSiatis Perry CEVP, GC AND SECRETARY2026-03-02$2.41M
SellSiatis Perry CEVP, GC AND SECRETARY2026-03-02$612K
SellSiatis Perry CEVP, GC AND SECRETARY2026-03-02$1.35M
SellSiatis Perry CEVP, GC AND SECRETARY2026-02-25$5.15M
SellSALEKI-GERHARDT AZITAEVP, CHIEF OPERATIONS OFFICER2025-08-12$8.41M
SellDonoghoe NicholasEVP, CHIEF BUS/STRAT OFFICER2025-08-05$2.00M
SellDonoghoe NicholasEVP, CHIEF BUS/STRAT OFFICER2025-08-05$641K
View all insider trades →

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

1

Filings (14d)

Data as of 2026-07-06
2026-07-06

AbbVie announced that its second-quarter 2026 earnings will include a $291 million pre-tax expense for acquired in-process research and development (IPR&D) and milestones, reducing both GAAP and adjusted earnings per share by $0.17. The company updated its adjusted earnings guidance for the quarter and the full year to reflect this charge. Its adjusted EPS is now expected to be between $3.57 and $3.61 for Q2, and between $13.91 and $14.11 for the full year.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

CUSIP

00287Y109, 00287Y10 , 00287Y909, 00287Y959, 00287y109

FAQ

Who are the top institutional investors holding ABBVIE INC (ABBV)?
Major stakeholders currently include BlackRock, Inc. ($32.8B), Vanguard Capital Management LLC ($25.0B), State Street CORP ($17.7B). Based on the latest 13F filings, there are a total of 4087 tracked investment funds and institutions maintaining positions in ABBV.
What is the overall institutional sentiment toward ABBV recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $28.9B, driven by 1861 managers accumulating shares while 1910 reduced their exposure.
Which institutions have been selling or reducing their ABBV positions?
In the latest period, 1713 funds trimmed their holdings, and 197 managers completely exited their positions. The aggregate reported sell value was $145.3B.
Are there any notable investors adding ABBV to their portfolios?
Yes, buying activity remains notable. 148 institutions opened new positions in {ticker}, and 1713 existing holders added to their shares. The total reported buy value for the quarter amounted to $127.1B.

Related Stocks

Same Sector

Other stocks in the same GICS sector

JNJ

Johnson & Johnson

Institutions Holding

4,604

Total reported value

$438.9B

3598 institutions currently hold both ABBV and this stock

View detail
LLY

Eli Lilly & Co

Institutions Holding

4,338

Total reported value

$730.5B

3386 institutions currently hold both ABBV and this stock

View detail
MRK

Merck & Co. INC.

Institutions Holding

3,721

Total reported value

$236.1B

3164 institutions currently hold both ABBV and this stock

View detail

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

6,151

Total reported value

$2.1T

3246 13F institutions increased their position this quarter

View detail
AMZN

Amazon.com INC

Institutions Holding

5,958

Total reported value

$1.5T

3029 13F institutions increased their position this quarter

View detail
NVDA

Nvidia CORP

Institutions Holding

5,766

Total reported value

$3.0T

2744 13F institutions increased their position this quarter

View detail

Developer Access

Access ABBV's institutional ownership data programmatically:

REST API

curl https://alphasmo.com/api/v1/market/stock/ABBV

CLI

npx alphasmo stocks get ABBV
Full API & MCP documentation →